<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="brief-report"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d1 20130915//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 39.96?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Bioinformatics</journal-id><journal-id journal-id-type="iso-abbrev">Bioinformatics</journal-id><journal-id journal-id-type="publisher-id">bioinformatics</journal-id><journal-id journal-id-type="hwp">bioinfo</journal-id><journal-title-group><journal-title>Bioinformatics</journal-title></journal-title-group><issn pub-type="ppub">1367-4803</issn><issn pub-type="epub">1367-4811</issn><publisher><publisher-name>Oxford University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4565027</article-id><article-id pub-id-type="doi">10.1093/bioinformatics/btv289</article-id><article-id pub-id-type="publisher-id">btv289</article-id><article-categories><subj-group subj-group-type="heading"><subject>Applications Notes</subject><subj-group subj-group-type="heading"><subject>Genome Analysis</subject></subj-group></subj-group></article-categories><title-group><article-title>Seq2pathway: an R/Bioconductor package for pathway analysis of next-generation sequencing data</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Bin</given-names></name></contrib><contrib contrib-type="author"><name><surname>Cunningham</surname><given-names>John M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>(Holly) Yang</surname><given-names>Xinan</given-names></name><xref ref-type="corresp" rid="btv289-COR1">*</xref></contrib><aff id="btv289-AFF1">Section of Hematology/Oncology, Department of Pediatrics, The University of Chicago, Chicago, IL, USA</aff></contrib-group><author-notes><corresp id="btv289-COR1">*To whom correspondence should be addressed.</corresp><fn id="btv289-FN1"><p>Associate Editor: Inanc Birol</p></fn></author-notes><pub-date pub-type="ppub"><day>15</day><month>9</month><year>2015</year></pub-date><pub-date pub-type="epub"><day>15</day><month>5</month><year>2015</year></pub-date><pub-date pub-type="pmc-release"><day>15</day><month>5</month><year>2015</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the							<pub-date pub-type="epub"/>. --><volume>31</volume><issue>18</issue><fpage>3043</fpage><lpage>3045</lpage><history><date date-type="received"><day>4</day><month>2</month><year>2015</year></date><date date-type="rev-recd"><day>31</day><month>3</month><year>2015</year></date><date date-type="accepted"><day>2</day><month>5</month><year>2015</year></date></history><permissions><copyright-statement>&#x000a9; The Author 2015. Published by Oxford University Press.</copyright-statement><copyright-year>2015</copyright-year><license xlink:href="http://creativecommons.org/licenses/by/4.0/" license-type="creative-commons"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p><bold>Summary</bold>: Seq2pathway is an R/Python wrapper for pathway (or functional gene-set) analysis of genomic loci, adapted for advances in genome research. Seq2pathway associates the biological significance of genomic loci with their target transcripts and then summarizes the quantified values on the gene-level into pathway scores. It is designed to isolate systematic disturbances and common biological underpinnings from next-generation sequencing (NGS) data. Seq2pathway offers Bioconductor users enhanced capability in discovering collective pathway effects caused by both coding genes and cis-regulation of non-coding elements.</p><p><bold>Availability and implementation:</bold> The package is freely available at <ext-link ext-link-type="uri" xlink:href="http://www.bioconductor.org/packages/release/bioc/html/seq2pathway.html">http://www.bioconductor.org/packages/release/bioc/html/seq2pathway.html</ext-link>.</p><p><bold>Contact</bold>: <email>xyang2@uchicago.edu</email></p><p><bold>Supplementary information:</bold>
<ext-link ext-link-type="uri" xlink:href="http://bioinformatics.oxfordjournals.org/lookup/suppl/doi:10.1093/bioinformatics/btv289/-/DC1">Supplementary data</ext-link> are available at <italic>Bioinformatics</italic> online.</p></abstract><counts><page-count count="3"/></counts></article-meta></front><body><sec><title>1 Introduction</title><p>Functional gene-set analysis (fGSA) improves biological interpretability of genomic features with respect to prior knowledge and has led to important biological discoveries (<xref rid="btv289-B7" ref-type="bibr">Khatri <italic>et&#x000a0;al.</italic>, 2012</xref>). Its power lies in the fact that it detects statistical significance over an entire dataset of gene-sets and yields biologically meaningful interpretations (<xref rid="btv289-B14" ref-type="bibr">Subramanian <italic>et&#x000a0;al.</italic>, 2005</xref>). Recently, researchers revealed driver pathways that predispose individuals to disease (<xref rid="btv289-B16" ref-type="bibr">Vandin <italic>et&#x000a0;al.</italic>, 2012</xref>) and shed light on the development of targeted therapy (<xref rid="btv289-B3" ref-type="bibr">Gonzalez-Perez <italic>et&#x000a0;al.</italic>, 2013</xref>) by performing fGSA on genes proximal to significantly disease-associated loci. However, with the increasing growth of genomic sequencing measurements, non-coding regulatory loci pose a critical challenge to fGSA, as nearly 99% of the nucleotides in the human genome do not code for proteins but instead richly harbor functional regulators of genes (<xref rid="btv289-B6" ref-type="bibr">Kellis <italic>et&#x000a0;al.</italic>, 2014</xref>).</p><p>&#x02018;Gene-based&#x02019; fGSA methods neglect non-coding regulatory information because they have no readily annotated gene function and cannot be assigned to a specific biological pathway. For example, HOMER (Hypergeometric Optimization of Motif EnRichment), a popular tool for discovering cis-regulatory regions before any subsequent fGSA, links genomic loci to only the nearest genes (<xref rid="btv289-B18" ref-type="bibr">Wang <italic>et&#x000a0;al.</italic>, 2011</xref>). Other fGSA algorithms take into account single-nucleotide polymorphisms (SNPs) only located in or near coding genes (<xref rid="btv289-B8" ref-type="bibr">Koster <italic>et&#x000a0;al.</italic>, 2014</xref>; <xref rid="btv289-B12" ref-type="bibr">Nam <italic>et&#x000a0;al.</italic>, 2010</xref>) or exonic mutations (<xref rid="btv289-B1" ref-type="bibr">Boca <italic>et&#x000a0;al.</italic>, 2010</xref>; <xref rid="btv289-B3" ref-type="bibr">Gonzalez-Perez <italic>et&#x000a0;al.</italic>, 2013</xref>; <xref rid="btv289-B9" ref-type="bibr">Leiserson <italic>et&#x000a0;al.</italic>, 2013</xref>).</p><p>&#x02018;Sequence-derived&#x02019; fGSA regarding the functional impact of not only coding genes, but also non-coding regulators, is necessary. A growing body of evidence supports the strategy of connecting genomic loci and coding genes using a many-to-many mapping and considering long-distance cis-regulation. First, non-coding regions richly harbor functional regulatory elements in humans (<xref rid="btv289-B6" ref-type="bibr">Kellis <italic>et&#x000a0;al.</italic>, 2014</xref>; <xref rid="btv289-B13" ref-type="bibr">Schierding <italic>et&#x000a0;al.</italic>, 2014</xref>). Second, nearly half of the disease-associated SNPs are located in gene deserts (<xref rid="btv289-B17" ref-type="bibr">Visel <italic>et&#x000a0;al.</italic>, 2009</xref>). Third, our recent study suggests that a disease-associated SNP located in an intron could be the enhancer of a neighboring gene rather than of its host gene (<xref rid="btv289-B15" ref-type="bibr">van den Boogaard <italic>et&#x000a0;al.</italic>, 2014</xref>).</p><p>The first sequence-derived fGSA method is GREAT (the Genomic Regions Enrichment of Annotations Tool) (<xref rid="btv289-B11" ref-type="bibr">McLean <italic>et&#x000a0;al.</italic>, 2011</xref>). GREAT quantifies an fGSA score by determining if the total number of loci within the regulatory domain of genes in a gene-set is greater than expected. The ChIP-Enrich method then empirically adjusts the length of the gene body and its surrounding non-coding sequence (<xref rid="btv289-B19" ref-type="bibr">Welch <italic>et&#x000a0;al.</italic>, 2014</xref>). However, both GREAT and ChIP-Enrich treat all loci equally, despite the fact that a threshold for significance is always experimentally context-dependent and arbitrary.</p><p>We propose a new sequence-derived fGSA tool named &#x02018;seq2pathway&#x02019; that fills the non-coding region gap in fGSA by considering quantitative sequencing measurements. We initially developed FAIME (Functional Analysis of Individual Microarray/RNAseq Expression) to compare the cumulative quantitative effects of genes inside an ontology (set of functionally related genes) with those outside, thus overcoming a number of difficulties in prior fGSA methods (<xref rid="btv289-B21" ref-type="bibr">Yang <italic>et&#x000a0;al.</italic>, 2012</xref>). We here provide the community a Bioconductor package that (i) quantifies the functional impact of both coding genes and non-coding loci, (ii) generalizes four fGSA methods, including FAIME, to variable next-generation sequencing (NGS) data and (iii) wraps gene locus definitions for human and mouse genomes from the GENCODE project (<xref rid="btv289-B4" ref-type="bibr">Harrow <italic>et&#x000a0;al.</italic>, 2012</xref>) into R objects.</p></sec><sec><title>2 Main features</title><p>Seq2pathway is designed for knowledge discovery using a variety of NGS data (e.g. ChIP-seq, RNA-seq, SNPs, etc) by taking the contribution of non&#x02010;coding loci and their experimental significance scores into consideration. Users can apply the &#x02018;seq2pathway&#x02019; function jointly, or in a two-step algorithm consisting of &#x02018;seq2gene&#x02019; and &#x02018;gene2pathway&#x02019; components separately (For workflow see <ext-link ext-link-type="uri" xlink:href="http://bioinformatics.oxfordjournals.org/lookup/suppl/doi:10.1093/bioinformatics/btv289/-/DC1">Supplementary Fig. S1</ext-link>).</p><p>The seq2gene step links both coding and non-coding regions to coding genes in a many-to-many mapping (For detailed Pseudo code see <ext-link ext-link-type="uri" xlink:href="http://bioinformatics.oxfordjournals.org/lookup/suppl/doi:10.1093/bioinformatics/btv289/-/DC1">Supplementary Fig. S2</ext-link>) (<xref rid="btv289-B22" ref-type="bibr">Yang <italic>et&#x000a0;al.</italic>, 2015b</xref>). Using seq2gene with a search radius of 100&#x02009;kb, our recent study <italic>in&#x000a0;vivo</italic> defined a novel cis-regulatory element from both ChIP-seq and transcriptomic data (<xref rid="btv289-B5" ref-type="bibr">Hoffmann <italic>et&#x000a0;al.</italic>, 2014</xref>). Compared with other methods, seq2gene outputs candidate targets with detailed loci-to-gene mappings (e.g. exon, intron, CDS (CoDing sequence), UTR (UnTranslated Region), promoter and neighbor). This feature allows researchers to understand the function of the region and design creative downstream analyses for the genomic locus hits, an effort only previously achieved by annotation tools HOMER and ChIP-Enrich.</p><p>The gene2pathway step integrates several cutting-edge fGSA algorithms, characterized by the improved FAIME method (<ext-link ext-link-type="uri" xlink:href="http://bioinformatics.oxfordjournals.org/lookup/suppl/doi:10.1093/bioinformatics/btv289/-/DC1">Supplementary Fig. S3</ext-link>). We also provide other three alternative methods: Fisher&#x02019;s exact test, the Kolmogorov&#x02013;Smirnov test, and the cumulative rank test (<xref rid="btv289-B14" ref-type="bibr">Subramanian <italic>et&#x000a0;al.</italic>, 2005</xref>). All of these implemented analyses condense gene-by-sample measurements (gene profiles) to gene-set-by-sample measurements (gene-set profiles), which are gene-coverage-difference tolerable and free of gene-set size preference for gene-sets with five or more genes (<ext-link ext-link-type="uri" xlink:href="http://bioinformatics.oxfordjournals.org/lookup/suppl/doi:10.1093/bioinformatics/btv289/-/DC1">Supplementary Figs S4A, S6A</ext-link>, and <ext-link ext-link-type="uri" xlink:href="http://bioinformatics.oxfordjournals.org/lookup/suppl/doi:10.1093/bioinformatics/btv289/-/DC1">S8A</ext-link>).</p><p>Significance of biologically-defined loci of genomic aberrations or functional elements has been lacking of attention than their recurrence. Confidence of threshold-based significance is likely to depend on the choice of genomic background and the test statistic; thus, empirical approaches are recommended (<xref rid="btv289-B2" ref-type="bibr">Glaab <italic>et&#x000a0;al.</italic>, 2012</xref>). Seq2pathway calculates empirical <italic>P</italic>-values for each gene-set in a sample by shuffling the gene scores derived from genomic locus hits of this sample to generate gene-set scores from the null hypothesis. This empirical assessment overcomes common biases of gene length in pathway analysis of NGS data (<ext-link ext-link-type="uri" xlink:href="http://bioinformatics.oxfordjournals.org/lookup/suppl/doi:10.1093/bioinformatics/btv289/-/DC1">Supplementary Figs S4B</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://bioinformatics.oxfordjournals.org/lookup/suppl/doi:10.1093/bioinformatics/btv289/-/DC1">S6B</ext-link>).</p><p>Additionally, we collapsed significant scores per gene when a gene was mapped to multiple neighboring genomic loci, removing the bias of linkage disequilibrium for the downstream pathway analysis (<ext-link ext-link-type="uri" xlink:href="http://bioinformatics.oxfordjournals.org/lookup/suppl/doi:10.1093/bioinformatics/btv289/-/DC1">Supplementary Fig. S6C</ext-link>).</p><p>Finally, researchers can run seq2pathway against user-supplied gene-sets and the wrapped Gene Ontology (GO). This feature essentially allows unbiased comparisons of methods and results.</p></sec><sec><title>3 Case study</title><p>To highlight the earlier features, we demonstrate the application of seq2pathway on a variety of different NGS datasets, point out the novel insights obtained only by seq2pathway, and summarize the take home message (<ext-link ext-link-type="uri" xlink:href="http://bioinformatics.oxfordjournals.org/lookup/suppl/doi:10.1093/bioinformatics/btv289/-/DC1">Supplementary Document</ext-link>).</p><p>We first compared seq2pathway with ChIP-Enrich and GREAT to test GO enrichment in a set of H3K27me3 peaks using the same criteria (<ext-link ext-link-type="uri" xlink:href="http://bioinformatics.oxfordjournals.org/lookup/suppl/doi:10.1093/bioinformatics/btv289/-/DC1">Supplementary Fig. S5</ext-link>, false discovery rate (FDR)&#x02009;&#x0003c;&#x02009;0.01, count &#x02265;5 and search radius&#x02009;=&#x02009;5&#x02009;kb). Both seq2pathway and GREAT identified the biological process GO:0008285 (negative regulation of cell proliferation), while seq2pathway concentrates better with less identified GO terms than the other two methods. Interestingly, the significance of GO:0003705 (distal enhancer region for RNA polymerase II), a molecular function significantly enriched by bivalent genes marked with both H3K4me3 and H3K27me3 (<xref rid="btv289-B10" ref-type="bibr">Li <italic>et&#x000a0;al.</italic>, 2013</xref>), was obtained only with seq2pathway (<ext-link ext-link-type="uri" xlink:href="http://bioinformatics.oxfordjournals.org/lookup/suppl/doi:10.1093/bioinformatics/btv289/-/DC1">Supplementary Fig. S5B</ext-link>).</p><p>We next tested 460 human height-associated SNP loci and compared the output with the seq2pathway (setting the parameter SNP&#x02009;=&#x02009;T) to the results of GREAT (Binomial FDR&#x02009;&#x0003c;&#x02009;0.05, observed regions &#x0003e;3, region fold enrich &#x0003e;2). We applied a search radius&#x02009;=&#x02009;5&#x02009;kb for both methods. The valuable biological processes obtained only with seq2pathway include GO:0001701 (<italic>in utero</italic> embryonic development) that was predicted recently (<xref ref-type="fig" rid="btv289-F1">Fig. 1</xref>) in a comprehensive study on human height (<xref rid="btv289-B20" ref-type="bibr">Wood <italic>et&#x000a0;al.</italic>, 2014</xref>).
<fig id="btv289-F1" orientation="portrait" position="float"><label>Fig. 1.</label><caption><p>The identification of biological process from 460 height-associated SNPs. (<bold>A</bold>) Results of both methods were comparable to the prediction of a comprehensive study on human height (<xref rid="btv289-B20" ref-type="bibr">Wood <italic>et&#x000a0;al.</italic>, 2014</xref>). (<bold>B</bold>) A demonstration of the case that both common and different genes are identified by two methods for the same GO term (GO:0006397). (<bold>C</bold>) Common and different SNPs are identified by two methods for the genes in Panel B. (<bold>D</bold>) Selective biological process terms identified by two or three methods, followed by the commonly identified (in black) and seq2pathway specifically identified (in blue, underlined) genes and SNPs shown in panels B&#x02013;C.</p></caption><graphic xlink:href="btv289f1p"/></fig>
</p><p>When we applied seq2pathway to RNA-seq data, individualized gene-set profiles allow the derivation of statistics at the pathway level directly rather than at the gene level. The advantages of seq2pathway lie in noise and dimension reduction, its desired biological interpretability, as well as a platform for novel integrative systems biology analysis (<xref rid="btv289-B22" ref-type="bibr">Yang <italic>et&#x000a0;al.</italic>, 2015a</xref>)</p></sec><sec><title>4 Conclusion</title><p>It is a breakthrough in genome analytics coordinates to assign region significance scores such as binding affinity estimates from ChIP-Seq onto a uniform gene-set scale. This feature facilitates the integrative analysis of multiple datasets (<xref rid="btv289-B22" ref-type="bibr">Yang <italic>et&#x000a0;al.</italic>, 2015a</xref>). The most critical issue in functionally interpreting genomic loci is to bridge non-coding regions with gene function. Seq2pathway offers the capacity to discover collective pathway effects caused by long-distance cis-regulation of non-coding elements. Importantly, seq2pathway enhances an alternative tool to integrate a number of &#x02018;omics&#x02019; datasets into a condensed space of quantitative gene-set scores. This functional level integration will help generate assumptions, constraints, and interpretation in systems biology.</p></sec>
<sec sec-type="supplementary-material">
<title>Supplementary Material</title>
<supplementary-material id="PMC_1" content-type="local-data">
<caption>
<title>Supplementary Data</title>
</caption>
<media mimetype="text" mime-subtype="html" xlink:href="supp_31_18_3043__index.html"/>
<media xlink:role="associated-file" mimetype="application" mime-subtype="pdf"
xlink:href="supp_btv289_seq2pathwaypackage_Suppl.pdf"/>
</supplementary-material>
</sec>
</body><back><ack><title>Acknowledgements</title><p>We acknowledge Joshua Stevens-Stein for manuscript proof-reading and initial package testing.</p></ack><sec><title>Funding</title><p><funding-source>NIH</funding-source> grant <award-id>R21CA167305-02</award-id>.</p><p><italic>Conflict of Interest:</italic> none declared.</p></sec><ref-list><title>References</title><ref id="btv289-B1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boca</surname><given-names>S.M.</given-names></name><etal/></person-group> (<year>2010</year>) <article-title>Patient-oriented gene set analysis for cancer mutation data</article-title>. <source>Genome Biol.</source>, <volume>11</volume>, <fpage>R112</fpage>.<pub-id pub-id-type="pmid">21092299</pub-id></mixed-citation></ref><ref id="btv289-B2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glaab</surname><given-names>E.</given-names></name><etal/></person-group> (<year>2012</year>) <article-title>EnrichNet: network-based gene set enrichment analysis</article-title>. <source>Bioinformatics</source>, <volume>28</volume>, <fpage>i451</fpage>&#x02013;<lpage>i457</lpage>.<pub-id pub-id-type="pmid">22962466</pub-id></mixed-citation></ref><ref id="btv289-B3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez-Perez</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2013</year>) <article-title>IntOGen-mutations identifies cancer drivers across tumor types</article-title>. <source>Nat. Methods</source>, <volume>10</volume>, <fpage>1081</fpage>&#x02013;<lpage>1082</lpage>.<pub-id pub-id-type="pmid">24037244</pub-id></mixed-citation></ref><ref id="btv289-B4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harrow</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2012</year>) <article-title>GENCODE: the reference human genome annotation for the ENCODE project</article-title>. <source>Genome Res.</source>, <volume>22</volume>, <fpage>1760</fpage>&#x02013;<lpage>1774</lpage>.<pub-id pub-id-type="pmid">22955987</pub-id></mixed-citation></ref><ref id="btv289-B5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffmann</surname><given-names>A.D.</given-names></name><etal/></person-group> (<year>2014</year>) <article-title>Foxf genes integrate tbx5 and hedgehog pathways in the second heart field for cardiac septation</article-title>. <source>PLoS Genet.</source>, <volume>10</volume>, <fpage>e1004604</fpage>.<pub-id pub-id-type="pmid">25356765</pub-id></mixed-citation></ref><ref id="btv289-B6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kellis</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2014</year>) <article-title>Defining functional DNA elements in the human genome</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source>, <volume>111</volume>, <fpage>6131</fpage>&#x02013;<lpage>6138</lpage>.<pub-id pub-id-type="pmid">24753594</pub-id></mixed-citation></ref><ref id="btv289-B7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khatri</surname><given-names>P.</given-names></name><etal/></person-group> (<year>2012</year>) <article-title>Ten years of pathway analysis: current approaches and outstanding challenges</article-title>. <source>PLoS Comput. Biol.</source>, <volume>8</volume>, <fpage>e1002375</fpage>.<pub-id pub-id-type="pmid">22383865</pub-id></mixed-citation></ref><ref id="btv289-B8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koster</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2014</year>) <article-title>Pathway-based analysis of GWAs data identifies association of sex determination genes with susceptibility to testicular germ cell tumors</article-title>.<source>Hum. Mol. Genet.</source>, <volume>23</volume>, <fpage>6061</fpage>&#x02013;<lpage>6068</lpage>.<pub-id pub-id-type="pmid">24943593</pub-id></mixed-citation></ref><ref id="btv289-B9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leiserson</surname><given-names>M.D.</given-names></name><etal/></person-group> (<year>2013</year>) <article-title>Simultaneous identification of multiple driver pathways in cancer</article-title>. <source>PLoS Comput. Biol.</source>, <volume>9</volume>, <fpage>e1003054</fpage>.<pub-id pub-id-type="pmid">23717195</pub-id></mixed-citation></ref><ref id="btv289-B10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Q.</given-names></name><etal/></person-group> (<year>2013</year>) <article-title>BGDB: a database of bivalent genes</article-title>. <source>Database</source>, <volume>2013</volume>, <fpage>bat057</fpage>.<pub-id pub-id-type="pmid">23894186</pub-id></mixed-citation></ref><ref id="btv289-B11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLean</surname><given-names>C.Y.</given-names></name><etal/></person-group> (<year>2011</year>) <article-title>Human-specific loss of regulatory DNA and the evolution of human-specific traits</article-title>. <source>Nature</source>, <volume>471</volume>, <fpage>216</fpage>&#x02013;<lpage>219</lpage>.<pub-id pub-id-type="pmid">21390129</pub-id></mixed-citation></ref><ref id="btv289-B12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nam</surname><given-names>D.</given-names></name><etal/></person-group> (<year>2010</year>) <article-title>GSA-SNP: a general approach for gene set analysis of polymorphisms</article-title>. <source>Nucleic Acids Res.</source>, <volume>38</volume>, <fpage>W749</fpage>&#x02013;<lpage>W754</lpage>.<pub-id pub-id-type="pmid">20501604</pub-id></mixed-citation></ref><ref id="btv289-B13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schierding</surname><given-names>W.</given-names></name><etal/></person-group> (<year>2014</year>) <article-title>The missing story behind genome wide association studies: single nucleotide polymorphisms in gene deserts have a story to tell</article-title>. <source>Front. Genet.</source>, <volume>5</volume>, <fpage>39</fpage>.<pub-id pub-id-type="pmid">24600475</pub-id></mixed-citation></ref><ref id="btv289-B14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subramanian</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2005</year>) <article-title>Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source>, <volume>102</volume>, <fpage>15545</fpage>&#x02013;<lpage>15550</lpage>.<pub-id pub-id-type="pmid">16199517</pub-id></mixed-citation></ref><ref id="btv289-B15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van den Boogaard</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2014</year>) <article-title>A common genetic variant within SCN10A modulates cardiac SCN5A expression</article-title>. <source>J. Clin. Invest.</source>, <volume>124</volume>, <fpage>1844</fpage>&#x02013;<lpage>1852</lpage>.<pub-id pub-id-type="pmid">24642470</pub-id></mixed-citation></ref><ref id="btv289-B16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vandin</surname><given-names>F.</given-names></name><etal/></person-group> (<year>2012</year>) <article-title>De&#x000a0;novo discovery of mutated driver pathways in cancer</article-title>. <source>Genome Res.</source>, <volume>22</volume>, <fpage>375</fpage>&#x02013;<lpage>385</lpage>.<pub-id pub-id-type="pmid">21653252</pub-id></mixed-citation></ref><ref id="btv289-B17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Visel</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2009</year>) <article-title>Genomic views of distant-acting enhancers</article-title>. <source>Nature</source>, <volume>461</volume>, <fpage>199</fpage>&#x02013;<lpage>205</lpage>.<pub-id pub-id-type="pmid">19741700</pub-id></mixed-citation></ref><ref id="btv289-B18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>D.</given-names></name><etal/></person-group> (<year>2011</year>) <article-title>Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA</article-title>. <source>Nature</source>, <volume>474</volume>, <fpage>390</fpage>&#x02013;<lpage>394</lpage>.<pub-id pub-id-type="pmid">21572438</pub-id></mixed-citation></ref><ref id="btv289-B19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Welch</surname><given-names>R.P.</given-names></name><etal/></person-group> (<year>2014</year>) <article-title>ChIP-Enrich: gene set enrichment testing for ChIP-seq data</article-title>.<source>Nucleic Acids Res.</source>, <volume>42</volume>, <fpage>e105</fpage>.<pub-id pub-id-type="pmid">24878920</pub-id></mixed-citation></ref><ref id="btv289-B20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wood</surname><given-names>A.R.</given-names></name><etal/></person-group> (<year>2014</year>) <article-title>Defining the role of common variation in the genomic and biological architecture of adult human height</article-title>. <source>Nat. Genet.</source>, <volume>46</volume>, <fpage>1173</fpage>&#x02013;<lpage>1186</lpage>.<pub-id pub-id-type="pmid">25282103</pub-id></mixed-citation></ref><ref id="btv289-B21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>X.</given-names></name><etal/></person-group> (<year>2012</year>) <article-title>Single sample expression-anchored mechanisms predict survival in head and neck cancer</article-title>. <source>PLoS Comput. Biol.</source>, <volume>8</volume>, <fpage>e1002350</fpage>.<pub-id pub-id-type="pmid">22291585</pub-id></mixed-citation></ref><ref id="btv289-B22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>X.</given-names></name><etal/></person-group> (<year>2015a</year>) <article-title>Systematic computation with functional gene-sets among leukemic and hematopoietic stem cells reveals a favorable prognostic signature for acute myeloid leukemia</article-title>. <source>BMC Bioinformatics</source>, <volume>16</volume>, <fpage>97</fpage>.<pub-id pub-id-type="pmid">25887548</pub-id></mixed-citation></ref><ref id="btv289-B23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>X.</given-names></name><etal/></person-group> (<year>2015b</year>) <article-title>Identification of epigenetic modifications that contribute to pathogenesis in therapy-related AML: effective integration of genome-wide histone modification with transcriptional profiles</article-title>. <source>BMC Med. Genomics</source>, <volume>8</volume>, <fpage>S2:S6</fpage>.</mixed-citation></ref></ref-list></back></article>